tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Options
Options Market Overview Unusual Options Activity
Popular
Most Active OptionsOptions Volume Leaders
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersKIRSKE DAVID

KIRSKE DAVID Insider Profile

4 Followers
KIRSKE DAVID, EVP & CFO at CTI BioPharma, holds 0.00 shares in CTI BioPharma (Ticker: CTIC).
See the Hottest Stocks Based on Insider Trading >
tipranks
KIRSKE DAVID

KIRSKE DAVID
CTI BioPharma (CTIC)
EVP & CFO

Not Ranked
KIRSKE DAVID has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

KIRSKE DAVID does not currently own shares as a corporate insider.
A breakdown of KIRSKE DAVID's holdings
See the Top Stocks by Insiders

Insider Roles

KIRSKE DAVID does not currently hold a role as a corporate insider.
Roles that KIRSKE DAVID holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by KIRSKE DAVID
See the Latest Stocks Traded by Insiders

KIRSKE DAVID's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CTIC
CTI BioPharma
Jun 26, 2023
―
Uninformative Sell
159.68K
$0.00
CTIC is no longer traded
KIRSKE DAVID has not reported any informative transactions for CTIC, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 12, 2021
Uninformative Buy
$3.72K
-
$0.98
―
Mar 11, 2022
Uninformative Buy
$7.59K
-
$2.10
―
Sep 20, 2022
Uninformative Buy
$20.08K
-
$2.11
―
Jan 03, 2023
Uninformative Buy
$1.09K
-
$5.10
―
Jun 16, 2022
Uninformative Sell
$55.00K
-
$0.94
―
List of latest transactions for each holding click on a transaction to see KIRSKE DAVID's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

KIRSKE DAVID insider profile FAQ

What is the percentage of profitable transactions made by KIRSKE DAVID?
The percentage of profitable transactions made by KIRSKE DAVID is ―.
    What is the average return per transaction made by KIRSKE DAVID?
    The average return per transaction made by KIRSKE DAVID is ―.
      What stocks does KIRSKE DAVID hold?
      KIRSKE DAVID holds: CTIC stocks.
        What was KIRSKE DAVID’s latest transaction?
        KIRSKE DAVID latest transaction was an Uninformative Sell of $159.68K.
          What was KIRSKE DAVID's most profitable transaction?
          KIRSKE DAVID’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is KIRSKE DAVID's role in CTI BioPharma?
            KIRSKE DAVID's role in CTI BioPharma is EVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.